Other Species / Isoforms
  DAT (rat)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsKsKCsVG
2 0
DAT (human) ______MsKskCsVG S2-p
DAT (mouse) ______MSKSkCSVG S2
DAT (rat) ______MsKsKCsVG S2-p
S4-p
____MsKsKCsVGPM
Upstream
3 0
Kinase, in vitro:
  • PKCA (human)
DAT (human) ____MsKskCsVGLM S4-p
DAT (mouse) ____MSKSkCSVGPM S4
DAT (rat) ____MsKsKCsVGPM S4-p
K5
___MsKsKCsVGPMs
0 1
DAT (human) ___MsKsKCsVGLMs K5
DAT (mouse) ___MSKSkCSVGPMS K5-m1
DAT (rat) ___MsKsKCsVGPMs K5
K5
___MsKsKCsVGPMs
1 0
DAT (human) ___MsKskCsVGLMs K5-ub
DAT (mouse) ___MSKSKCSVGPMS K5
DAT (rat) ___MsKsKCsVGPMs K5
S7-p
_MsKsKCsVGPMssV
Upstream
Downstream
6 2
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • protein conformation
Kinase, in vitro:
  • PKACA (human)
  • PKCA (human)
Treatment
  • okadaic_acid
  • phorbol_ester
DAT (human) _MsKskCsVGLMssV S7-p
DAT (mouse) _MSKSkCSVGPMSSV S7
DAT (rat) _MsKsKCsVGPMssV S7-p
S12-p
KCsVGPMssVVAPAK
Upstream
6 0
Treatment
  • OAG
  • okadaic_acid
  • U0126
DAT (human) kCsVGLMssVVAPAK S12-p
DAT (mouse) kCSVGPMSSVVAPAK S12
DAT (rat) KCsVGPMssVVAPAK S12-p
S13-p
CsVGPMssVVAPAKE
Upstream
4 0
Kinase, in vitro:
  • CAMK2A (human)
  • PKCA (human)
Treatment
  • OAG
  • okadaic_acid
  • phorbol_ester
  • U0126
DAT (human) CsVGLMssVVAPAKE S13-p
DAT (mouse) CSVGPMSSVVAPAKE S13
DAT (rat) CsVGPMssVVAPAKE S13-p
S21-p
VVAPAKEsNAVGPRE
Upstream
1 0
Treatment
  • OAG
  • okadaic_acid
DAT (human) VVAPAKEPNAVGPKE P21
DAT (mouse) VVAPAKEPNAVGPRE P21
DAT (rat) VVAPAKEsNAVGPRE S21-p
I48
QLTNSTLINPPQtPV
1 1
DAT (human) QLTSSTLtNPRQsPV T48-p
DAT (mouse) QLTNSTLINPPQtPV I48
DAT (rat) QLTNSTLINPPQtPV I48
T53-p
TLINPPQtPVEAQER
Upstream
Downstream
4 1
Effects on Modified Protein
  • activity, induced
Kinase, in vitro:
  • ERK1 (human)
Treatment
  • benzatropine
  • cocaine
  • dopamine
  • levamfetamine
  • metamfetamine
  • okadaic_acid
  • phorbol_ester
DAT (human) TLtNPRQsPVEAQDR S53-p
DAT (mouse) TLINPPQtPVEVQER T53-p
DAT (rat) TLINPPQtPVEAQER T53-p
T62-p
VEAQEREtWSKKIDF
Upstream
2 0
Treatment
  • LY294002
DAT (human) VEAQDREtWGKKIDF T62-p
DAT (mouse) VEVQERETWSKKIDF T62
DAT (rat) VEAQEREtWSKKIDF T62-p
T277
TMPYVVLTALLLRGV
0 1
DAT (human) TMPYVVLtALLLRGV T278-p
DAT (mouse) TMPYVVLTALLLRGV T277
DAT (rat) TMPYVVLTALLLRGV T277
T285
ALLLRGVTLPGAMDG
0 1
DAT (human) ALLLRGVtLPGAIDG T286-p
DAT (mouse) ALLLRGVTLPGAMDG T285
DAT (rat) ALLLRGVTLPGAMDG T285
C580-pa
IYATYKFcsLPGSFR
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
DAT (human) IYAAYKFCSLPGSFR C581
DAT (mouse) IYATYKFCSLPGSFR C580
DAT (rat) IYATYKFcsLPGSFR C580-pa
S581-p
YATYKFcsLPGSFRE
Upstream
1 0
Treatment
  • LY294002
DAT (human) YAAYKFCSLPGSFRE S582
DAT (mouse) YATYKFCSLPGSFRE S581
DAT (rat) YATYKFcsLPGSFRE S581-p
Y592
SFREKLAYAItPEKD
0 1
DAT (human) SFREKLAyAIAPEKD Y593-p
DAT (mouse) SFREKLAYAITPEkD Y592
DAT (rat) SFREKLAYAItPEKD Y592
T595-p
EKLAYAItPEKDHQL
Upstream
1 0
Treatment
  • U0126
DAT (human) EKLAyAIAPEKDREL A596
DAT (mouse) EKLAYAITPEkDRQL T595
DAT (rat) EKLAYAItPEKDHQL T595-p
K598
AYAItPEKDHQLVDR
0 1
DAT (human) AyAIAPEKDRELVDR K599
DAT (mouse) AYAITPEkDRQLVDR K598-ub
DAT (rat) AYAItPEKDHQLVDR K598
T612-p
RGEVRQFtLRHWLLL
Upstream
2 0
Treatment
  • U0126
DAT (human) RGEVRQFtLRHWLKV T613-p
DAT (mouse) RGEVRQFTLRHWLLV T612
DAT (rat) RGEVRQFtLRHWLLL T612-p